ASTRO’s Efforts with Promoting Radiopharmaceutical Therapy in Radiation Oncology
Posted: November 19, 2024ASTRO has been actively developing resources for radiopharmaceutical therapies and continues to advocate for radiation oncology in many ways. Here is a roundup of efforts over the past several years.
The ROCR Act: Past, Present and Future
Posted: November 6, 2024As 2024 winds down, this is a good time to take stock of radiation oncology’s efforts to advance Medicare payment reform legislation, known as the Radiation Oncology Case Rate (ROCR) Value Based Program Act (S. 4330/HR 8404).
